A. Uzan

3.6k total citations
77 papers, 3.0k citations indexed

About

A. Uzan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, A. Uzan has authored 77 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cellular and Molecular Neuroscience, 33 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in A. Uzan's work include Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (18 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). A. Uzan is often cited by papers focused on Neuroscience and Neuropharmacology Research (32 papers), Receptor Mechanisms and Signaling (18 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). A. Uzan collaborates with scholars based in France, United States and Algeria. A. Uzan's co-authors include G. Le Fur, C. Guérémy, C. Renault, M.C. Dubroeucq, Jesús Bénavidès, C. Malgouris, F. Imbault, J Mizoule, A. Flamier and F. Guilloux and has published in prestigious journals such as Nature, Journal of Neuroscience and Journal of Neurochemistry.

In The Last Decade

A. Uzan

73 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Uzan France 26 1.8k 1.4k 293 272 267 77 3.0k
C. Guérémy France 25 1.7k 0.9× 1.3k 0.9× 216 0.7× 265 1.0× 342 1.3× 51 2.6k
P.H. Wu Canada 34 2.2k 1.2× 1.7k 1.2× 429 1.5× 373 1.4× 108 0.4× 92 3.6k
M.C. Dubroeucq France 18 1.4k 0.7× 925 0.7× 175 0.6× 220 0.8× 185 0.7× 24 2.0k
Tony Priestley United States 23 2.6k 1.4× 2.3k 1.7× 492 1.7× 352 1.3× 149 0.6× 50 3.8k
C. Renault France 18 1.3k 0.7× 957 0.7× 176 0.6× 191 0.7× 194 0.7× 25 1.9k
Dixon M. Woodbury United States 30 1.3k 0.7× 1.1k 0.8× 340 1.2× 447 1.6× 137 0.5× 82 3.1k
Gene C. Palmer United States 27 1.2k 0.6× 1.0k 0.8× 337 1.2× 98 0.4× 103 0.4× 112 2.2k
John W. Ferkany United States 28 1.8k 1.0× 1.3k 0.9× 351 1.2× 306 1.1× 118 0.4× 59 2.5k
Cristina Cosi France 27 1.1k 0.6× 939 0.7× 223 0.8× 150 0.6× 160 0.6× 51 2.1k
John L. Musachio United States 31 1.2k 0.7× 1.8k 1.3× 250 0.9× 152 0.6× 259 1.0× 80 3.0k

Countries citing papers authored by A. Uzan

Since Specialization
Citations

This map shows the geographic impact of A. Uzan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Uzan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Uzan more than expected).

Fields of papers citing papers by A. Uzan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Uzan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Uzan. The network helps show where A. Uzan may publish in the future.

Co-authorship network of co-authors of A. Uzan

This figure shows the co-authorship network connecting the top 25 collaborators of A. Uzan. A scholar is included among the top collaborators of A. Uzan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Uzan. A. Uzan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uzan, A.. (2005). Quel avenir pour la pharmacologie dans la recherche thérapeutique ?. Annales Pharmaceutiques Françaises. 63(4). 269–283.
2.
Pratt, Jeremy, et al.. (1998). Enoxaparin Reduces Cerebral Edemaafter Photothrombotic Injury in the Rat. Pathophysiology of Haemostasis and Thrombosis. 28(2). 78–85. 17 indexed citations
3.
Uzan, A., et al.. (1996). [ON THE THIAMINES WITH AN OPEN THIAZOLE RING. STUDY OF O,S-DIACETYLTHIAMINE].. PubMed. 21. 655–66. 5 indexed citations
4.
André, Patrick, Patricia Hainaud, Claire Bal dit Sollier, et al.. (1996). GUINEA PIG BLOOD: A MODEL FOR THE PHARMACOLOGIC MODULATION OF THE GPIb/IX-VWF AXIS. Thrombosis Research. 83(2). 127–136. 6 indexed citations
5.
6.
7.
Fromage, Nadine, Patrice Denèfle, Bernard Cambou, et al.. (1991). Synthesis, purification and biological properties of a truncated mutant form of human tissue plasminogen activator produced in E. Coli. Fibrinolysis and Proteolysis. 5(3). 187–190. 5 indexed citations
8.
9.
Saulnier‐Blache, Jean Sébastien, Mohammed Taouis, Michèle Dauzats, et al.. (1989). Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.. Journal of Pharmacology and Experimental Therapeutics. 251(3). 1193–1198. 3 indexed citations
10.
Malgouris, C., et al.. (1989). Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. Journal of Neuroscience. 9(11). 3720–3727. 152 indexed citations
11.
Malgouris, C., Pascale Guicheney, A. Uzan, et al.. (1987). QUANTITATIVE AUTORADIOGRAPHIC DETERMINATION OF BINDING SITES FOR A PERIPHERAL BENZODIAZEPINE LIGAND ([3H]PK 11195) IN HUMAN IRIS. Fundamental and Clinical Pharmacology. 1(3). 161–167.
12.
13.
Mestre, M, et al.. (1985). Pharmacology of peripheral type benzodiazepine receptors in the heart.. PubMed. 192. 175–86. 8 indexed citations
14.
Bénavidès, Jesús, F. Guilloux, A. Uzan, et al.. (1984). Opposite effects of an agonist, R05-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice. Life Sciences. 34(26). 2613–2620. 92 indexed citations
15.
Rougeot, C., et al.. (1984). PK 10139 and quinidine: interactions with digoxin concentrations in rats and dogs. Journal of Pharmacy and Pharmacology. 36(5). 347–349.
16.
Fur, G. Le, F. Imbault, A. Flamier, et al.. (1983). Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamide. Life Sciences. 32(16). 1839–1847. 316 indexed citations
17.
Fur, G. Le, F. Guilloux, Pierre Rufat, et al.. (1983). Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. Life Sciences. 32(16). 1849–1856. 204 indexed citations
18.
Uzan, A., et al.. (1979). The antithrombotic activity of viquidil, a cerebral vasodilator.. PubMed. 29(3). 508–11. 3 indexed citations
19.
Fur, G. Le, et al.. (1979). Relationships between plasma corticosteroids and benzodiazepines in stress.. Journal of Pharmacology and Experimental Therapeutics. 211(2). 305–308. 106 indexed citations
20.
Uzan, A., et al.. (1966). [Influence of alpha-chymotrypsin on the distribution of tritiated tetracycline in rats with an experimental granuloma].. PubMed. 21(2). 457–72.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Guérémy Breakdown of academic impact, for papers by P.H. Wu Breakdown of academic impact, for papers by M.C. Dubroeucq Breakdown of academic impact, for papers by Tony Priestley Breakdown of academic impact, for papers by C. Renault Breakdown of academic impact, for papers by Dixon M. Woodbury Breakdown of academic impact, for papers by Gene C. Palmer Breakdown of academic impact, for papers by John W. Ferkany Breakdown of academic impact, for papers by Cristina Cosi Breakdown of academic impact, for papers by John L. Musachio
Rankless by CCL
2026